Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients

NCT00395291 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT00395291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00395291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients
Lead sponsor
University of Virginia
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2006
Completion date
May 31, 2010
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, end stage renal disease